Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)

It is unknown whether individuals with monoclonal B-cell lymphocytosis (MBL) are at risk for adverse outcomes associated with chronic lymphocytic leukemia (CLL), such as the risk of non-hematologic cancer. We identified all locally-residing individuals diagnosed with high count MBL at Mayo Clinic be...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Benjamin M., Chaffee, Kari G., Moreira, Jonathan, Schwager, Susan M., Cerhan, James R., Call, Timothy G., Kay, Neil E., Slager, Susan L., Shanafelt, Tait D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839962/
https://www.ncbi.nlm.nih.gov/pubmed/26310541
http://dx.doi.org/10.1038/leu.2015.235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839962/
https://www.ncbi.nlm.nih.gov/pubmed/26310541
http://dx.doi.org/10.1038/leu.2015.235

Ejemplares similares